Evolving spectrum of treatment for CTEPH
- 1 September 2020
- journal article
- review article
- Published by Wolters Kluwer Health in Current Opinion in Pulmonary Medicine
- Vol. 26 (5) , 406-413
Abstract
Purpose of review The present review provides an update on treatment of chronic thromboembolic pulmonary hypertension (CTEPH), a rare form of pulmonary hypertension characterized by precapillary pulmonary hemodynamic parameters with chronic thrombotic occlusion of the pulmonary vasculature. Recent findings Pulmonary thromboendarectomy (PTE) remains the recommended treatment for patients with surgically accessible disease. Recent data suggest that patients preoperatively bridged with medical therapy may have improved outcomes but further research is needed. Riociguat improves hemodynamics, right ventricular function, quality of life, and functional capacity and is the drug of choice for patients with inoperable/persistent disease. Recently published data suggest that endothelin receptor blockers and treprostinil may also have a role in medical management of this patient population. A growing body of evidence indicates that in experienced centers balloon pulmonary angioplasty (BPA) may be a well tolerated and effective adjunct to pharmacological treatment for patients with inoperable disease affecting subsegmental vasculature. Untreated CTEPH carries significant morbidity and mortality. Recent publications provide a wealth of data on safety and efficacy of BPA for inoperable subsegmental disease, but its precise fit in the treatment algorithm, both pharmacological and procedural, requires further investigation. PTE remains the procedure of choice for surgically accessible disease.Keywords
This publication has 48 references indexed in Scilit:
- Surgical specimens, haemodynamics and long-term outcomes after pulmonary endarterectomyThorax, 2013
- Riociguat for the Treatment of Chronic Thromboembolic Pulmonary HypertensionNew England Journal of Medicine, 2013
- Refined Balloon Pulmonary Angioplasty for Inoperable Patients with Chronic Thromboembolic Pulmonary HypertensionCirculation: Cardiovascular Interventions, 2012
- Surgical treatment of chronic thromboembolic pulmonary hypertensionEuropean Respiratory Journal, 2012
- Pulmonary Endarterectomy: Recent Changes in a Single Institution's Experience of More Than 2,700 PatientsThe Annals of Thoracic Surgery, 2012
- Occlusion pressure analysis role in partitioning of pulmonary vascular resistance in CTEPHEuropean Respiratory Journal, 2012
- Percutaneous Transluminal Pulmonary Angioplasty Markedly Improves Pulmonary Hemodynamics and Long-Term Prognosis in Patients With Chronic Thromboembolic Pulmonary HypertensionCirculation Journal, 2012
- Chronic Thromboembolic Pulmonary Hypertension (CTEPH)Circulation, 2011
- Preoperative Partitioning of Pulmonary Vascular Resistance Correlates With Early Outcome After Thromboendarterectomy for Chronic Thromboembolic Pulmonary HypertensionCirculation, 2004
- Long-Term Outcome after Pulmonary ThromboendarterectomyAmerican Journal of Respiratory and Critical Care Medicine, 1999